MoneyWorks4Me

Syschem (India) informs about annual report

25 Aug 2022 Evaluate
Syschem (India) has informed that it enclosed Annual Report for the Financial Year 2021-22.

The above information is a part of company’s filings submitted to BSE.

Syschem (India) Share Price

32.19 0.17 (0.53%)
25-Aug-2026 11:43 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1915.00
Dr. Reddys Labs. 1186.15
Cipla 1420.00
Lupin 2174.60
Zydus Lifesciences 1095.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: